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SUMMARY
We report five cases of Wegener's granulomatosis all of whom had clinical
and histological evidence of disease activity at presentation and in whom
autoantibodies to neutrophil antigens were detected. This test may prove useful
for the diagnosis of this serious condition and help to monitor disease activity
during treatment.
INTRODUCTION
Wegener's granulomatosis is a necrotising granulomatous arteritis I which
preferentially involves the kidney and upper and lower respiratory tracts.2,3 Its
aetiology is unknown and its pathogenesis not entirely characterised.4 Despite
the lack of understanding of the immune mechanisms involved in the disease,
it can be successfully treated with immunosuppressive agents.2 5 Diagnosis is
usually based on clinical and histological data.2 5,6 There are a variety of clinical
manifestations which include proteinuria, microscopic haematuria, impaired
renal function, fever without evidence of infection, ocular inflammation, otitis,
sinusitis, tracheitis, haemoptysis, pulmonary infiltrates and evidence of granulo-
matous vasculitis usually on nasal, lung or renal biopsy.
A number of non-specific immunological abnormalities have been reported
including circulating immune complexes,7 8 rheumatoid factor and IgG and IgA
autoantibodies. These have not proved helpful in diagnosis or monitoring disease
activity and are present in relatively few patients. Laboratory monitoring of
disease activity has relied on non-specific markers such as the erythrocyte
sedimentation rate and C-reactive protein.9
Van der Woude et al reported the presence of IgG autoantibodies to neutrophil
antigens in patients with active Wegener's granulomatosis.'0 More recently
Lockwood et al have described a radioimmunoassay method to quantitate the
level of these autoantibodies and have shown that they are detectable in certain
types of vasculitis including Wegener's granulomatosis.16
PATIENTS AND METHODS
Five patients (three female, two male) were studied. Serum samples were tested
for the presence of antineutrophil antibodies by the indirect immunofluorescent
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and radioimmunoassay methods described by Lockwood et al.'6 In all patients
the diagnosis of Wegener's granulomatosis was confirmed by histological
examination of tissue biopsy and the pre-treatment serum samples showed the
presence of antineutrophil antibodies (Table).
TABLE
Neutrophil Renal Positive
Case Age Sex autoantibody impairment biopsy
1 53 F +ve No Nasal
2 28 M + ve No Lung
Nasal
3 41 M +ve Yes Nasal
Renal
4 33 F + ve Yes Nasal
Skin
5 62 F + ve Yes Skin
(Postmortem)
CASE 1
A 53-year-old woman presented with epistaxis, nasal congestion, deafness and
a painful swollen left calf. On examination, her temperature was 39°C. She had
rhinitis and otitis media. There were signs of consolidation at the apex of the left
lung. Venography confirmed the clinical impression of an extensive left leg
venous thrombosis. A chest X-ray demonstrated cavitating lesions in both lung
fields. A nasal biopsy was reported as showing necrotising arteritis. Urinalysis and
microscopy were negative. Treatment with 80mg prednisolone and 2mg/kg
cyclophosphamide dailyinduced clinical remission. Pre-treatment serumsamples
showed the presence of antineutrophil antibodies both by indirect immuno-
fluorescence and radioimmunoassay. Unfortunately, she died three months after
diagnosis from a cerebrovascular accident.
CASE 2
A 28-year-old man presented with earache, deafness, nasal congestion,
epistaxis, cough and pleuritic chest pain. On examination, his temperature was
39-2C. He had episcleritis, rhinitis and a serous effusion in the right middle ear.
Signs of consolidation were present in the left lung apex. A chest X-ray revealed
the presence of circular opacities in both lung fields. Biopsy of the nasal septum
and percutaneous needle biopsy oflung confirmed the diagnosis. Serum samples
showed the presence of antibodies to neutrophil antigens. Treatment with 60mg
prednisolone and 2mg/kg cyclophosphamide induced clinical remission. Repeat
serum samples showed no evidence ofantineutrophil antibodies either by indirect
immunofluorescence or the radioimmunoassay.
CASE 3
A 41-year-old man presented with facial pain, recurrent epistaxis and jaundice.
On examination, his temperature was 38-5C. Apart from jaundice, he had no
other stigmata of liver disease. Biochemical investigations included bilirubin
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102 umol/l, alkaline phosphatase 45 U/1, gamma GT 771 U/i, ALT 1295 U/I
and AST 365 U/I. Viral hepatitis, leptospiral and toxiplasma screening was
negative. Initial urinalysis was negative except for bilirubinuria. Facial X-rays
showed opacification of both maxillary antra which were subsequently drained.
He developed right hypochondrial pain two weeks after admission and ultrasound
scan and percutaneous cholangiogram showed a dilated gallbladder and dilated
common hepaticduct. Hedeveloped pleuritic chest pain, cough and haemophysis
and on examination there was a left-sided pleural rub. Investigations revealed
microscopic haematuria, pulmonary infiltrates on chest X
-ray and multiple
perfusion defects on isotope lung scan. He developed rapidly progressive origuric
renal failure. Renal biopsy demonstrated crescentic glomerulonephritis. He was
treated with 60mg prednisolone and 2mg/kg cyclophosphamide daily but there
was no recovery of renal function despite remission of other clinical features. He
was subsequently maintained on twice weekly haemodialysis until receiving a
cadaveric renal allograft in November 1985. Repeat assay for antineutrophil
antibodies are consistently negative.
CASE 4
A 33.-year.-old woman presented with general malaise and weight loss for three
months. She developed arthralgia, skin rash, cough, haemoptysis and sinusitus in
the two weeks prior to admission. On examination her temperature was 37-80C.
She had tender nodular erythematous swellings on the right ankle and left wrist
and a florid haemorrhagic rash. Investigations revealed rapidly progressive renal
failure with proteinuria and haematuria on urinalysis and haemogranular casts
and microscopic haematuria on microscopy. A chest X-ray showed pulmonary
infiltrates. Nasal biopsy was consistent with the diagnosis. Treatment with 60mg
prednisolone and 2mg/kg cyclophosphamide induced clinical remission with
recovery of renal function. Significant proteinuria 2-5g/24 hours persists at
follow up.
CASE 5
A 62-year-old woman presented with a three week history of a flu-like illness,
cough and sputum. On examination, her temperature was 38 40C. She was
anaemic and in congestive cardiac failure. Consolidation was present at the left
lung base. Investigations revealed rapidly progressive renal failure. A skin biopsy
was reported as vasculitis. Renal arteriography was suggestive of multiple micro-
aneurysms. Peritoneal dialysis was instituted but was complicated by peritonitis.
She died from cardiac arrest during haemodialysis. Post mortem demonstrated
a myocardial infarct secondary to haemorrhage into an atheromatous plaque
occluding the right coronary artery. The diagnosis was confirmed by the finding
of necrotising granulomatous arteries in lungs and spleen. The renal lesion was
crescentic glomerulonephritis.
DISCUSSION
Wegener's granulomatosis is a serious and life-threatening condition in which
a rapid and accurate diagnosis may improve the clinical outcome." Untreated,
the one year survival in patients with renal disease is 20 per cent.2 5 It can
be effectively treated with immunosuppressive drugs, usually a combination of
steroids and cyclophosphamide.'2, 13, 14 Azathioprine and plasma exchange may
also have a role in treatment.'5
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Autoantibodies against neutrophils and monocytes in Wegener's granulomatosis
have been described by Van der Woude et al 10 and were reported as being
specific for this disease. Lockwood et al have confirmed the presence of
autoantibodies to neutrophil antigens in this condition, but have shown that they
may also be detected in other forms of vasculitis.16 We report five patients with
clinical and histopathological evidence of Wegener's granulomatosis in whom
neutrophil autoantibodies were present at time of diagnosis and in whom the
antibody test became negative when clinical remission was achieved. Testing for
neutrophil autoantibodies may soon become part of the screening investigations
in vasculitic disorders and testing for these immunoglobulins may be of benefit
when biopsy material is inconclusive or unobtainable. Rapid serological diagnosis
would enable earlier treatment to be initiated in an attempt to reduce overall
morbidity and mortality ofthis disease. This assay would also appear to be a more
reliable and sensitive method formonitoring disease activity than the non -specific
markers such as ESR or C -reactive protein.
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